Oligonucleotide Synthesis Market, by Equipment & Services (Equipment/Synthesizer, Reagents, and Services (Oligo Synthesis, Modification, and Purification)), by Technology (Column-based, and Microarray-based), by Nucleic Acid (DNA and RNA), by Application

Oligonucleotide Synthesis Market, by Equipment & Services (Equipment/Synthesizer, Reagents, and Services (Oligo Synthesis, Modification, and Purification)), by Technology (Column-based, and Microarray-based), by Nucleic Acid (DNA and RNA), by Application (Drug Discovery and Therapeutics), by End User (Academic Research Institutes, Diagnostic Laboratories, and Pharmaceutical-Biotechnology Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Oligonucleotides are commonly used as primers for polymerase chain reaction (PCR), PCR assays, and panels for biologically related genes. Antisense oligonucleotides are used to reduce levels of protein synthesis by inhibiting mRNA processing or translation. Other uses of oligonucleotides include DNA sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), and nucleic acid aptamers. Moreover, many pharmaceutical companies are focusing on developing nucleic acid-based therapeutics due to which the demand of oligonucleotide is increasing. Hence, market players are focusing on expanding their manufacturing facilities, which is expected to boost the market growth over the forecast period. For instance, in August 2020, Agilent Technologies Inc., announced the expansion of its state-of-the-art production facility in Frederick, Colorado, which develops manufactures oligos that hold potential to be used as treatments for diseases such as COVID-19, cardiovascular disease, cancer, rare and infectious diseases, and other conditions.
Market Dynamics:
Key players are focusing on various inorganic growth strategies such as collaborations, partnerships and agreements, which is expected to propel the growth of the global oligonucleotide synthesis market during the forecast period. For instance, on August 05, 2022, Evotec SE, a drug discovery and development company entered into a strategic partnership with Secarna Pharmaceuticals GmbH & Co. KG, a drug discovery company, for the development of antisense oligonucleotide therapies.
Moreover, in November 2021, CSBio, a peptide and instrumentation manufacturing company entered into a collaboration with Sunresin, a supplier of ion exchange resin and absorption & separation resin for the development of an optimized polystyrene resin for commercial scale oligonucleotide synthesis.
Key features of the study:
This report provides in-depth analysis of the global oligonucleotide synthesis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oligonucleotide synthesis market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
Key companies covered as a part of this study include Thermo Fisher Scientific, Sigma-Aldrich Corporation, GE Healthcare, Integrated DNA Technologies, Inc., TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, Shanghai SynTheAll Pharmaceutical Co., CUSABIO Technology LLC, Synbio Technologies, GENEWIZ, Eurofins Scientific, Agilent Technologies, Kaneka Eurogentec S.A., and LGC, Biosearch Technologies
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, market expansion, and marketing tactics
The global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market.
Detailed Segmentation:
Global Oligonucleotide Synthesis Market, By Equipment & Services:
Equipment/Synthesizer
Reagents
Services
Oligo Synthesis
Modification
Purification
Global Oligonucleotide Synthesis Market, By Technology:
Column-based
Microarray-based
Global Oligonucleotide Synthesis Market, By Nucleic Acid Type:
DNA
RNA
Global Oligonucleotide Synthesis Market, By Application:
Drug Discovery
Therapeutics
Global Oligonucleotide Synthesis Market, By End User:
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-Biotechnology Companies
Global Oligonucleotide Synthesis Market, By Region:
North America
By Equipment & Services
Equipment/Synthesizer
Reagents
Services
Oligo Synthesis
Modification
Purification
By Technology
Column-based
Microarray-based
By Nucleic Acid Type
DNA
RNA
By Application
Drug Discovery
Therapeutics
By End User
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-Biotechnology Companies
By Country:
U.S.
Canada
Latin America
By Equipment & Services
Equipment/Synthesizer
Reagents
Services
Oligo Synthesis
Modification
Purification
By Technology
Column-based
Microarray-based
By Nucleic Acid Type
DNA
RNA
By Application
Drug Discovery
Therapeutics
By End User
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-Biotechnology Companies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Equipment & Services
Equipment/Synthesizer
Reagents
Services
Oligo Synthesis
Modification
Purification
By Technology
Column-based
Microarray-based
By Nucleic Acid Type
DNA
RNA
By Application
Drug Discovery
Therapeutics
By End User
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-Biotechnology Companies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Equipment & Services
Equipment/Synthesizer
Reagents
Services
Oligo Synthesis
Modification
Purification
By Technology
Column-based
Microarray-based
By Nucleic Acid Type
DNA
RNA
By Application
Drug Discovery
Therapeutics
By End User
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-Biotechnology Companies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Equipment & Services
Equipment/Synthesizer
Reagents
Services
Oligo Synthesis
Modification
Purification
By Technology
Column-based
Microarray-based
By Nucleic Acid Type
DNA
RNA
By Application
Drug Discovery
Therapeutics
By End User
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-Biotechnology Companies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Equipment & Services
Equipment/Synthesizer
Reagents
Services
Oligo Synthesis
Modification
Purification
By Technology
Column-based
Microarray-based
By Nucleic Acid Type
DNA
RNA
By Application
Drug Discovery
Therapeutics
By End User
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-Biotechnology Companies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Thermo Fisher Scientific
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sigma-Aldrich Corporation
GE Healthcare
Integrated DNA Technologies, Inc.
TriLink BioTechnologies, Inc
BioAutomation Corporation
Twist Bioscience
Shanghai SynTheAll Pharmaceutical Co.
CUSABIO Technology LLC
Synbio Technologies
GENEWIZ
Eurofins Scientific
Agilent Technologies
Kaneka Eurogentec S.A.
LGC, Biosearch Technologies
“*” marked represents similar segmentation in other categories in the respective section.